Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early recognition and optimal treatment of delirium in patients with advanced cancer
2009-013403-55Phase 3Active
- Sponsor
- VU university medical center
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of olanzapine and haloperidol in delirium, sponsored by VU university medical center. Primary endpoints: Sensitivity of DOS scale vs DRS-R-98, Specificity of DOS scale vs DRS-R-98 and 3 more. Started Jul 2009; status: active.
02
Drugs
olanzapinehaloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on 2009-013403-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013403-55.